These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8122285)

  • 1. The development of a bedside algorithm capable of targeting anti-endotoxins to the responder subpopulations.
    Birmingham MC; Nix DE; Cumbo TJ; Collins DA; Wels PB; Schentag JJ
    Ther Drug Monit; 1993 Dec; 15(6):503-9. PubMed ID: 8122285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.
    McCloskey RV; Straube RC; Sanders C; Smith SM; Smith CR
    Ann Intern Med; 1994 Jul; 121(1):1-5. PubMed ID: 8198341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
    Ziegler EJ; Fisher CJ; Sprung CL; Straube RC; Sadoff JC; Foulke GE; Wortel CH; Fink MP; Dellinger RP; Teng NN
    N Engl J Med; 1991 Feb; 324(7):429-36. PubMed ID: 1988827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projected impact of monoclonal anti-endotoxin antibody therapy.
    Bates DW; Lee TH
    Arch Intern Med; 1994 Jun; 154(11):1241-9. PubMed ID: 8203991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.
    Barriere SL; Guglielmo BJ
    Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monoclonal antibody against endotoxin.
    Zarowitz BJ
    DICP; 1991; 25(7-8):778-83. PubMed ID: 1949939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide.
    Fink MP
    Crit Care Med; 1993 Feb; 21(2 Suppl):S32-9. PubMed ID: 8428494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy using the anti-endotoxin antibody HA-1A (Centoxin) in patients with sepsis syndrome; fair results following protocol selection of patients].
    Costongs LG; Speelman P; van Lieshout JJ; van Deventer SJ; Lubbers MJ; Schipper HG
    Ned Tijdschr Geneeskd; 1993 Feb; 137(7):355-60. PubMed ID: 8437634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiendotoxin antibodies: a dead end?
    Cross AS
    Ann Intern Med; 1994 Jul; 121(1):58-60. PubMed ID: 8198349
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiendotoxin antibodies.
    Siegel JP
    Ann Intern Med; 1995 Feb; 122(4):315-6. PubMed ID: 7825773
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody to endotoxin in the treatment of gram-negative sepsis.
    McCabe WR
    JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564763
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody to endotoxin in the treatment of gram-negative sepsis.
    van Deventer S
    JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765
    [No Abstract]   [Full Text] [Related]  

  • 14. [Endotoxin in the clinic and in experiments].
    Rumiantsev AG; Kasatkin VN; Kanaeva ES
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):110-4. PubMed ID: 7941855
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of clinical study design on cost-effectiveness projections for the treatment of gram-negative sepsis with human anti-endotoxin antibody.
    Linden PK; Angus DC; Chelluri L; Branch RA
    J Crit Care; 1995 Dec; 10(4):154-64. PubMed ID: 8924965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
    Gorelick KJ; Chmel H
    Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival in selected patients with gram-negative sepsis after adjunctive therapy with HA-1A.
    van Dissel JT; van Furth R; Compier BA; Feuth HD; Frolich M
    Lancet; 1993 Apr; 341(8850):959-60. PubMed ID: 8096292
    [No Abstract]   [Full Text] [Related]  

  • 18. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-endotoxin monoclonal antibodies.
    Ziegler EJ; Smith CR
    N Engl J Med; 1992 Apr; 326(17):1165. PubMed ID: 1552929
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-endotoxin monoclonal antibodies.
    Warren HS; Danner RL; Munford RS
    N Engl J Med; 1992 Apr; 326(17):1153-7. PubMed ID: 1552919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.